Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.
Effects of an acute bout of physical exercise on reward functioning in healthy adults.
An evolutionary medicine perspective on Neandertal extinction.
The Journal of Molecular Diagnostics: 20 Years of Education and Training.
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies. J Oncol Pract. 2019 11; 15(11):575-583.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Drugs, Investigational
Genomics
High-Throughput Nucleotide Sequencing
Humans
Molecular Targeted Therapy
Mutation
Neoplasms
Precision Medicine
Prognosis
authors with profiles
Richard Schilsky